PUBLISHER: The Business Research Company | PRODUCT CODE: 1957632
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957632
Pharmaceutical quality control is a systematic process designed to ensure the identity, strength, purity, and consistency of pharmaceutical products. It involves rigorous testing of raw materials, in-process samples, and finished products to meet established standards, ensuring the safety, efficacy, and compliance of medicines before they reach consumers.
The main products in pharmaceutical quality control include consumables, services, and instruments. Pharmaceutical quality control consumables encompass essential materials and supplies used in laboratory testing and analysis, such as culture media, reagents, assay kits, filters, and pipette tips, which are critical for verifying the safety and quality of pharmaceutical products. These solutions can be deployed through various models, including cloud-based, web-based, and on-premises systems.
Tariffs have impacted the pharmaceutical quality control market by increasing the cost of imported analytical instruments, reagents, and consumables, leading to higher operational expenses. Segments such as chromatography systems, spectroscopy instruments, and microbiological testing services are most affected, particularly in regions like North America and Europe that depend heavily on imports. While tariffs have slowed procurement and increased costs, they have also encouraged local manufacturing, investment in domestic instrument production, and development of cost-efficient quality control solutions.
The pharmaceutical quality control market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical quality control market statistics, including pharmaceutical quality control industry global market size, regional shares, competitors with a pharmaceutical quality control market share, detailed pharmaceutical quality control market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical quality control industry. This pharmaceutical quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical quality control market size has grown rapidly in recent years. It will grow from $9.08 billion in 2025 to $10 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to limited access to advanced qc instruments, reliance on manual testing methods, growing pharmaceutical manufacturing, increasing regulatory compliance requirements, expansion of microbiological testing capabilities.
The pharmaceutical quality control market size is expected to see strong growth in the next few years. It will grow to $14.59 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to integration of cloud-based and ai-enabled qc solutions, rising adoption of automated analytical instruments, increasing investment in validation and qualification services, growing focus on sterility assurance and stability testing, expansion of contract research and development partnerships. Major trends in the forecast period include adoption of advanced chromatography and spectroscopy instruments, increasing demand for microbiological and sterility testing services, expansion of stability testing and validation services, rising focus on endotoxin and bio burden analysis, growing requirement for on-premises and cloud-based quality control solutions.
The mounting demand for biosimilars is anticipated to boost the pharmaceutical quality control market ahead. Biosimilars are biologic medicines closely mirroring approved reference versions, showing no significant clinical variances in safety, purity, or strength. This uptick mainly follows patent expirations on pioneer biologics, paving the way for cost-effective options. Pharmaceutical quality control safeguards biosimilar reliability, purity, and uniformity through stringent comparisons to references, aiding approvals and standards. For example, in January 2023, Cardinal Health Inc., a US healthcare firm, stated that by January 2022, the FDA had cleared 33 biosimilars with 21 on shelves; by 2023, approvals hit 40, with 25 marketable. Thus, the surging biosimilar need is fueling the pharmaceutical quality control market.
Leading firms in the pharmaceutical quality control market are embracing tech upgrades like intelligent software platforms to refine testing precision and adherence. Intelligent software platforms in pharmaceutical quality control are cutting-edge digital tools deploying automation, analytics, and AI to boost test reliability, speed, and regulatory fit. For instance, in June 2025, Dycine Pharmaceuticals Ltd., an India-based pharma company, unveiled an AI-powered quality control system to elevate production benchmarks and product dependability. It employs sophisticated AI to spot irregularities, track live data, and simplify compliance across manufacturing. Highlights include predictive insights, auto-reports, and smooth ties to current setups, cutting mistakes, ramping efficiency, and upholding batch consistency.
In October 2024, the United States Pharmacopeial Convention, a US independent science body, purchased Stratix Labs for an undisclosed sum. This step broadens USP's microbial offerings to curb contamination hazards and fill control strategy voids, delivering safer, superior pharma products to users. Stratix Labs Corporation is a US provider of state-of-the-art microbiological testing.
Major companies operating in the pharmaceutical quality control market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, SGS S.A., Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Mettler-Toledo International Inc., bioMerieux SA, Shimadzu Scientific Instruments Inc., Waters Corporation, Randox Laboratories Ltd., SOLVIAS AG, Esco Micro Pte. Ltd, REMI Elektrotechnik Limited, Lucideon Limited, BRAM-COR S.p.A.
North America was the largest region in the pharmaceutical quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmaceutical quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceutical quality control market consists of revenues earned by entities by providing services such as analytical testing services, microbiological testing services, stability testing services, sterility assurance services, and validation and qualification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical quality control market also includes sales of reagents and assay kits, filters and membranes, sterility testing systems, and chromatography columns and consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Quality Control Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmaceutical quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical quality control market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.